Share Buyback Program Declared by Doximity (NASDAQ:DOCS)

Doximity (NASDAQ:DOCS) declared that its board has authorized a stock repurchase plan on Thursday, February 5th, RTT News reports. The company plans to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to purchase up to 8% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its shares are undervalued.

Analyst Ratings Changes

Several equities analysts have recently commented on DOCS shares. Morgan Stanley upgraded shares of Doximity from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $62.00 to $65.00 in a report on Monday, December 15th. Raymond James Financial restated a “strong-buy” rating on shares of Doximity in a research note on Monday, December 29th. Truist Financial set a $62.00 price target on Doximity in a research note on Thursday, January 8th. Evercore ISI reissued an “outperform” rating on shares of Doximity in a research note on Thursday, January 8th. Finally, Canaccord Genuity Group set a $48.00 price objective on Doximity in a report on Thursday, January 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Doximity has a consensus rating of “Moderate Buy” and a consensus price target of $64.95.

Doximity Stock Performance

Shares of NASDAQ DOCS opened at $33.30 on Friday. The business’s 50-day simple moving average is $43.16 and its 200-day simple moving average is $56.92. Doximity has a 52 week low of $32.66 and a 52 week high of $85.21. The firm has a market cap of $6.27 billion, a price-to-earnings ratio of 33.30, a P/E/G ratio of 4.10 and a beta of 1.39.

Doximity (NASDAQ:DOCS) last announced its earnings results on Thursday, February 5th. The company reported $0.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter in the previous year, the company earned $0.45 earnings per share. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, equities research analysts forecast that Doximity will post 0.99 earnings per share for the current year.

Key Stories Impacting Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Q3 results beat consensus on both EPS and revenue: $0.46 EPS (vs. ~$0.45) and roughly $185.1M revenue (up ~10% YoY), with strong profitability (net margin ~36.6%). This shows the core business remains profitable and growing. Doximity Announces Fiscal 2026 Third Quarter Financial Results
• Positive Sentiment: User engagement and product traction remain healthy: the company highlighted record engagement (over 1M quarterly active prescribers) and a sequential jump in workflow-product users, indicating demand for its clinical workflow and professional network offerings. Doximity Announces Fiscal 2026 Third Quarter Financial Results
• Neutral Sentiment: Analyst write-ups dig into metric details (growth rates, engagement vs. estimates) that can guide revisions; they confirm the quarter beat but focus investor attention on forward trends. Here’s What Key Metrics Tell Us About Doximity (DOCS) Q3 Earnings
• Negative Sentiment: Management’s forward guidance disappointed: Q4 revenue was guided to ~$143.0–$144.0M vs. consensus near $150.2M, and FY26 revenue guidance (~$642.5–$643.5M) was marginally below Street estimates — the guidance miss is the main driver of the sell-off. Doximity Announces Fiscal 2026 Third Quarter Financial Results
• Negative Sentiment: Market reaction was sharp: shares plunged after-hours and trading volume spiked as investors sold into the weaker guidance despite the quarter’s beats. Momentum and multiple compression are likely contributors to today’s downside. Doximity Stock Is Collapsing After Hours: Here’s Why

About Doximity

Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”

The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.